Genomics is old hat and proteomics is now where it's at, according to Richard Christopherson.

Newly listed biotech and equipment supplier NuSep is involved in clinical trials for its wondrously named Sperm Sorter.

A variant in the gene responsible for the production of the interleukin-7 receptor linked to multiple sclerosis.

Research shows that the use of one antibiotic increases resistance but also increases the carriage of resistance genes against other classes of antibiotics.

ANSTO and Siemens will build a $10 million nuclear medicine facility in Sydney.

Diagnostic microbiology could be turned on its head with the use of real-time PCR in the clinical setting.

Mayne Pathology (ASX:MAY) has agreed to provide Sydney-based Medsaic's DotScan test for leukaemia and lymphoma in four states in Australia, with an official launch of the technology at Mayne Health Laverty Pathology in Sydney today.

Breast cancer researchers and health-service agencies in NSW have formed a consortium to establish a national tissue bank, containing annotated tissues from breast cancer patients, as resource for Australian researchers.

A molecular geneticist working on cancer at Westmead Hospital's Children's Medical Research Institute (CMRI) has made a chance discovery that throws new light on the mechanisms that immortalise cancer cells.

A Sydney company is hoping pathologists will be making room next to their flow cytometers for a new technology which provides doctors with a detailed profile of leukaemias and lymphomas, setting the scene for tailored treatment.